WRKF

Alison Kodjak

Louisiana officials announced a deal Wednesday with Asegua Therapeutics, a subsidiary of Gilead Sciences, that would allow the state to provide hepatitis C treatment to its Medicaid and prison populations. They also secured the necessary clearance from the federal government Wednesday for a novel approach to paying for the drugs and expect the program to start July 15.

More than 130 people in the U.S. die of an opioid overdose every day. One of the most effective ways to save lives is to get those struggling with addiction treated with medication to stop their cravings. But a loophole in federal law might block at least one new opioid-addiction drug from coming to market for years.

Many patients have to try several medications before finding one that works for them and that they can stick with.

Updated at 6:01 p.m. ET

The federal Department of Health and Human Services is proposing to roll back an Obama-era policy intended to protect transgender people from discrimination in health care.

The Trump administration issued a new rule Thursday that gives health care workers leeway to refuse to provide services like abortion, sterilization or assisted suicide, if they cite a religious or conscientious objection.

The rule, issued by the Department of Health and Human Services, is designed to protect the religious rights of health care providers and religious institutions.

According to a statement issued by HHS's Office for Civil Rights, the new rule affirms existing conscience protections established by Congress.

Copyright 2019 NPR. To see more, visit https://www.npr.org.

ARI SHAPIRO, HOST:

If there's a single issue that's defining the Democratic field of 2020 presidential candidates, it's health care, Medicare for All, to be precise.

(SOUNDBITE OF ARCHIVED RECORDING)

Consumers, lawmakers and industry players all seem to agree that prescription drugs prices are too high. What they can't always agree on is whom to blame.

On Tuesday, though, fingers are expected to point toward pharmacy benefit managers, the industry's mysterious middlemen.

The Senate Finance Committee will hear from executives from the biggest pharmacy benefit managers, led by CVS Caremark and Cigna's Express Scripts.

As the heat turns up on drug manufacturers who determine the price of insulin and the health insurers and middlemen who determine what patients pay, one company — Cigna's Express Scripts — announced Wednesday it will take steps by the end of the year to help limit the drug's cost to consumers.

Express Scripts, which manages prescription drug insurance for more than 80 million people, is launching a "patient assurance program" that Steve Miller, Cigna's chief clinical officer, says "caps the copay for a patient at $25 a month for their insulin — no matter what."

Copyright 2019 NPR. To see more, visit https://www.npr.org.

STEVE INSKEEP, HOST:

Copyright 2019 NPR. To see more, visit https://www.npr.org.

AUDIE CORNISH, HOST:

Copyright 2019 NPR. To see more, visit https://www.npr.org.

DAVID GREENE, HOST:

Pages